Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Francois Baclesse | OTHER |
| Centre Hospitalier Universitaire de Caen | OTHER |
| Institut de cancérologie Strasbourg Europe | OTHER |
| Centre Oscar Lambret, Lille, France |
Not provided
Not provided
Not provided
Not provided
Analysis of the individual radiosensitivity in pediatric oncology
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Radiosensitivity | Experimental | Patients who agree to participate in this research study will have blood sample collected to perform the RadioDtect test |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood sample | Biological | Blood sample collection : 2 X 5 ml |
|
| Measure | Description | Time Frame |
|---|---|---|
| Prospectively validate the discriminating capacities of the RadioDtect© individual radiosensitivity blood test on the occurrence of early radio-induced toxicities. | The validation will be based on ATM protein quantification assay to predict acute toxicities | 24 months |
| Prospectively validate the discriminating capacities of the RadioDtect© individual radiosensitivity blood test on the occurrence of early radio-induced toxicities. | evaluation of acute toxicities of grade ≥ 2 to 3 months according to NCI-CTCAE v4.03 criteria | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Prospectively validate the discriminating capacities of the RadioDtect individual radiosensitivity blood test protein assay according on the occurrence of late radiation-induced toxicity at 12 months | The validation will be based on ATM protein quantification assay to predict late toxicities | 12 months |
| Prospectively validate the discriminating capacities of the RadioDtect individual radiosensitivity blood test protein assay according on the occurrence of late radiation-induced toxicity at 12 months |
Not provided
Inclusion Criteria:
Exclusion criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sandrine PEREIRA, PhD | Contact | 0643957510 | spereira@neolys-diagnostics.fr | |
| Jennifer RUOS | Contact | jruos@fondation-force.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre François Baclesse | Recruiting | Caen | France |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D011832 | Radiation Injuries |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
| UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
evaluation of late toxicities of grade ≥ 2, according to NCI-CTCAE v4.03 criteria |
| 12 months |
| Centre Oscar Lambret | Not yet recruiting | Lille | France |
|
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |